MedPath

Wetsuit and Life Jacket Induced Effects on Spirometry and VO2 in Windsurfers

Not Applicable
Completed
Conditions
Exercise
Ventilation
Interventions
Diagnostic Test: resting standard spirometry
Diagnostic Test: maximum exercise testing
Registration Number
NCT03440294
Lead Sponsor
University Hospital, Brest
Brief Summary

The purpose of this study is to investigate the effect of wearing both neoprene suit and life jacket on respiratory capacities at rest and cardiopulmonary capacities during exercise in windsurfers.

Detailed Description

Windsurfers will perform resting spirometry and exercise test on cycle ergometer until exhaustion in two conditions: with or without equipment. The investigators will measure Forced Vital Capacity, FEV1 peak flow at rest and oxygen uptake, carbon dioxide consumption, ventilation at each step of the incremental exercise and at exhaustion.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
34
Inclusion Criteria
  • Male or female aged 18 to 35
  • Do not contraindicate any of the investigations in the study
  • Being affiliated to a social security system
  • free, informed and written consent
  • Have already performed a cardiopulmonary exercise test without any electrocardiographic abnormality
  • Subject practicing windsurfing (whatever the level of practice (leisure or competition))
Exclusion Criteria
  • Subjects < 18 years old
  • Pregnant woman
  • Inability to consent
  • Taking any of the following: oral or inhaled Beta 2 short-acting or long-acting mimetics, oral or inhaled corticosteroids, oral anti-leukotrienes.
  • Abnormalities in the resting ECG pattern

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
without neoprene suit and life jacketresting standard spirometryRealization of the following examinations WITHOUT neoprene suit and life jacket : * resting standard spirometry * maximum exercise testing. No drug and no placebo will be used in this arm.
without neoprene suit and life jacketmaximum exercise testingRealization of the following examinations WITHOUT neoprene suit and life jacket : * resting standard spirometry * maximum exercise testing. No drug and no placebo will be used in this arm.
with neoprene suit and life jacketmaximum exercise testingRealization of the following examinations WITH neoprene suit and life jacket : * resting standard spirometry * maximum exercise testing. No drug and no placebo will be used in this arm.
with neoprene suit and life jacketresting standard spirometryRealization of the following examinations WITH neoprene suit and life jacket : * resting standard spirometry * maximum exercise testing. No drug and no placebo will be used in this arm.
Primary Outcome Measures
NameTimeMethod
Forced Vital Capacity (FVC in L) at rest.1 day

spirometry at rest

Secondary Outcome Measures
NameTimeMethod
Peak Flow1 day

PF (peak flow in L/s)

carbon dioxide production1 day

VCO2 ( in L/min)

mean flow rates1 day

mean expiratory flow rates in L/ s at 75%, 50% and 25% of FVC (MEF 75, MEF 50, MEF 25).

Forced Expiratory Volume1 day

FEV1 (in L)

maximal ventilation1 day

VE (ventilation in L/min)

oxygen consumption1 day

VO2 ( in L/min)

tidal volume1 day

VT (in L)

breathing frequency1 day

RF (in breaths/min)

Trial Locations

Locations (1)

University hospital

🇫🇷

Brest, France

© Copyright 2025. All Rights Reserved by MedPath